Top Page
China Innovation Investment Limited
(1217)
China Innovation Investment Limited (1217) vs. iShares MSCI Hong Kong ETF (EWH)
China Innovation Investment Limited Business Overview & Revenue Model
China Innovation Investment Limited Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 20.26M | 3.12M | 20.15M | -26.73M | -3.64M |
| Gross Profit | 19.15M | 2.15M | 19.22M | -27.62M | -4.55M |
| EBITDA | 5.91M | 3.24M | 6.73M | -32.94M | -9.03M |
| Net Income | 5.00M | 2.19M | 5.76M | -34.01M | -9.88M |
Balance Sheet | |||||
| Total Assets | 548.58M | 550.22M | 564.03M | 612.68M | 656.35M |
| Cash, Cash Equivalents and Short-Term Investments | 299.84M | 177.96M | 137.63M | 156.54M | 225.14M |
| Total Debt | 1.38M | 2.23M | 475.00K | 1.39M | 2.26M |
| Total Liabilities | 5.87M | 2.55M | 770.00K | 1.68M | 2.60M |
| Stockholders Equity | 542.71M | 547.67M | 563.26M | 611.00M | 653.75M |
Cash Flow | |||||
| Free Cash Flow | 178.84M | 28.56M | -15.37M | -19.35M | -1.77M |
| Operating Cash Flow | 178.84M | 28.62M | -14.95M | -19.35M | -1.77M |
| Investing Cash Flow | -4.97M | 6.18M | 9.14M | 16.79M | 6.78M |
| Financing Cash Flow | -854.00K | -883.00K | -915.00K | -871.00K | -894.00K |
China Innovation Investment Limited Technical Analysis
China Innovation Investment Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | HK$61.04M | 5.93 | 11.69% | ― | 1.92% | ― | |
65 Neutral | £5.07B | 8.05 | 5.57% | 5.02% | 25.79% | -17.21% | |
54 Neutral | HK$423.21M | ― | -2.95% | ― | 50.91% | 81.77% | |
53 Neutral | HK$166.42M | 32.50 | 0.92% | ― | 545.43% | 100.00% | |
| ― | HK$12.11M | ― | -136.82% | ― | ― | ― | |
41 Neutral | HK$357.28M | ― | -3.77% | ― | 9.10% | 66.31% | |
| ― | HK$468.49M | ― | -38.46% | ― | ― | ― |
China Innovation Investment Limited Corporate Events
China Innovation Investment Limited has issued a positive profit alert, indicating a significant increase in profits for the first half of 2025. The company expects a profit of approximately HK$23 million, marking an over 180% rise compared to the same period in 2024, driven by favorable investment returns from the Hong Kong stock market.
China Innovation Investment Limited has reported suspected fraudulent activities using its name, involving unauthorized use of its name on online platforms, false documents, and impersonation scams. The company has clarified that it has no association with these activities and has taken steps to protect its rights, including reporting to the authorities and issuing anti-fraud statements. The announcement underscores the potential impact of these fraudulent activities on the company’s legitimate rights and interests, urging the public to exercise caution and verify the authenticity of any investment opportunities purportedly associated with the company.
China Innovation Investment Limited released a supplemental announcement to its 2024 Annual Report, providing additional details about its share option scheme. Notably, no share options were canceled during the year, and the options granted to Ms. Qin Han will vest on 29 September 2024. The announcement clarifies the status of share options for former directors and consultants, all of which have lapsed as of the end of 2024.
China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$ 0.044 as of June 30, 2025. This financial update provides stakeholders with insights into the company’s current valuation, potentially impacting investor perceptions and market positioning.
China Innovation Investment Limited announced its unaudited net asset value per share as of May 31, 2025, which stands at approximately HK$0.045. This announcement provides stakeholders with an insight into the company’s financial health and market positioning, potentially impacting investor confidence and future investment decisions.
China Innovation Investment Limited announced that all proposed resolutions at their 2024 Annual General Meeting were passed unanimously by shareholders. The resolutions included the re-election of independent non-executive directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of a general mandate to the directors. This unanimous approval reflects strong shareholder support and positions the company for continued stability and strategic decision-making.
China Innovation Investment Limited has announced a pre-conditional voluntary cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited, representing approximately 13.27% of its issued share capital. This move, subject to certain pre-conditions and conditions, aims to enhance the Offeror’s stake in Elife Holdings, potentially impacting the company’s market positioning and shareholder dynamics.
China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$0.046 as of April 30, 2025. This financial update provides stakeholders with a snapshot of the company’s financial health, potentially impacting investor perception and market positioning.